Placebo controls in clinical trials: concerns about use in relapse prevention studies in schizophrenia. Academic Article uri icon

Overview

publication date

  • September 9, 2016

Research

keywords

  • Antipsychotic Agents
  • Clinical Trials as Topic
  • Placebos
  • Schizophrenia
  • Secondary Prevention

Identity

Scopus Document Identifier

  • 85016445543

Digital Object Identifier (DOI)

  • 10.1136/bmj.i4728

PubMed ID

  • 27613560

Additional Document Info

volume

  • 354